Logo image
Back
Black Sorghum Phenolic Extract Modulates Platelet Activation and Platelet Microparticle Release
Journal article   Open access   Peer reviewed

Black Sorghum Phenolic Extract Modulates Platelet Activation and Platelet Microparticle Release

Borkwei Ed Nignpense, Kenneth A. Chinkwo, Christopher L. Blanchard and Abishek B. Santhakumar
Nutrients, Vol.12(6), 1760
12/06/2020
DOI: https://doi.org/10.3390/nu12061760
PMID: 32545505
pdf
Black Sorghum Phenolic Extract Modulates Platelet Activation and Platelet Microparticle Release583.77 kBDownloadView
Published (Version of record)CC BY V4.0,  Open Access
url
Black Sorghum Phenolic Extract Modulates Platelet Activation and Platelet Microparticle ReleaseView
Published (Version of record)CC BY V4.0,  Open

Related links

Metrics

48 Record Views
16 Times Cited - Web of Science

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Abstract

black sorghum polyphenols platelets platelet microparticles atherosclerosis
Platelet hyper-activation and platelet microparticles (PMPs) play a key role in the pathogenesis of cardiovascular diseases. Dietary polyphenols are believed to mimic antiplatelet agents by blunting platelet activation receptors via its antioxidant phenomenon. However, there is limited information on the anti-platelet activity of grain-derived polyphenols. The aim of the study is to evaluate the effects of sorghum extract (Shawaya short black 1 variety), an extract previously characterised for its high antioxidant activity and reduction of oxidative stress-related endothelial dysfunction, on platelet aggregation, platelet activation and PMP release. Whole blood samples collected from 18 healthy volunteers were treated with varying non-cytotoxic concentrations of polyphenol-rich black sorghum extract (BSE). Platelet aggregation study utilised 5 mu g/mL collagen to target the GPVI pathway of thrombus formation whereas adenine phosphate (ADP) was used to stimulate the P2Y1/P2Y12 pathway of platelet activation assessed by flow cytometry. Procaspase-activating compound 1 (PAC-1) and P-selectin/CD62P were used to evaluate platelet activation- related conformational changes and degranulation respectively. PMPs were isolated from unstimulated platelets and quantified by size distribution and binding to CD42b. BSE treatment significantly reduced both collagen-induced platelet aggregation and circulatory PMP release at 40 mu g/mL (p <0.001) when compared to control. However, there was no significant impact of BSE on ADP-induced activation-dependent conformational change and degranulation of platelets. Results of this study suggest that phenolic rich BSE may confer cardio-protection by modulating specific signalling pathways involved in platelet activation and PMP release.

Details

Logo image